Profiel
Alice Chen is currently the Director at Automera Pte Ltd.
She is also currently the Executive Vice President at Accelerator Services Corp.
Previously, she worked as the Director at Qwell Pharmaceuticals, Inc. Dr. Chen holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Actieve functies van Alice Chen
| Bedrijven | Functie | Begin |
|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01-01-2017 |
Eerdere bekende functies van Alice Chen
| Bedrijven | Functie | Einde |
|---|---|---|
Qwell Pharmaceuticals, Inc.
 Qwell Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Qwell Pharmaceuticals, Inc. developed small molecule drugs for oncology indications. It was a start-up biotechnology company devoted to small-molecule development derived from a plant source that have a potent ability to fight tumors and excess inflammation of skin cells. The company was founded in 2008 and was headquartered in Seattle, WA. | Director/Board Member | - |
Opleiding van Alice Chen
| Stanford University | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Qwell Pharmaceuticals, Inc.
Qwell Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Qwell Pharmaceuticals, Inc. developed small molecule drugs for oncology indications. It was a start-up biotechnology company devoted to small-molecule development derived from a plant source that have a potent ability to fight tumors and excess inflammation of skin cells. The company was founded in 2008 and was headquartered in Seattle, WA. | Health Technology |
